113 related articles for article (PubMed ID: 28723361)
1. Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy.
Kluth LA; Xylinas E; Rieken M; Kent M; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Bing MT; Gupta A; Sewell JM; Konety BR; Todenhöfer T; Schwentner C; Masson-Lecomte A; Vordos D; Roghmann F; Noldus J; Razmaria AA; Smith ND; Comploj E; Pycha A; Rink M; Baniel J; Mano R; Novara G; Aziz A; Fritsche HM; Brisuda A; Bivalacqua T; Gontero P; Boorjian SA; Vickers AJ; Shariat SF
Eur Urol Focus; 2015 Aug; 1(1):75-81. PubMed ID: 28723361
[TBL] [Abstract][Full Text] [Related]
2. Karnofsky performance status predicts overall survival, cancer-specific survival, and progression-free survival following radical cystectomy for urothelial carcinoma.
Evers PD; Logan JE; Sills V; Chin AI
World J Urol; 2014 Apr; 32(2):385-91. PubMed ID: 23756991
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of a molecular marker panel for prediction of recurrence and cancer-specific survival after radical cystectomy.
Lotan Y; Bagrodia A; Passoni N; Rachakonda V; Kapur P; Arriaga Y; Bolenz C; Margulis V; Raj GV; Sagalowsky AI; Shariat SF
Eur Urol; 2013 Sep; 64(3):465-71. PubMed ID: 23571005
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients.
Kluth LA; Rieken M; Xylinas E; Kent M; Rink M; Rouprêt M; Sharifi N; Jamzadeh A; Kassouf W; Kaushik D; Boorjian SA; Roghmann F; Noldus J; Masson-Lecomte A; Vordos D; Ikeda M; Matsumoto K; Hagiwara M; Kikuchi E; Fradet Y; Izawa J; Rendon R; Fairey A; Lotan Y; Bachmann A; Zerbib M; Fisch M; Scherr DS; Vickers A; Shariat SF
Eur Urol; 2014 Nov; 66(5):913-9. PubMed ID: 24331151
[TBL] [Abstract][Full Text] [Related]
5. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy.
Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF
Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854
[TBL] [Abstract][Full Text] [Related]
6. Oncological impact of inflammatory biomarkers in elderly patients treated with radical cystectomy for urothelial bladder cancer.
Mari A; Muto G; Di Maida F; Tellini R; Bossa R; Bisegna C; Campi R; Cocci A; Viola L; Grosso A; Scelzi S; Lapini A; Carini M; Minervini A
Arab J Urol; 2020 Aug; 19(1):2-8. PubMed ID: 33763243
[TBL] [Abstract][Full Text] [Related]
7. Comorbidity and performance indices as predictors of cancer-independent mortality but not of cancer-specific mortality after radical cystectomy for urothelial carcinoma of the bladder.
Mayr R; May M; Martini T; Lodde M; Comploj E; Pycha A; Strobel J; Denzinger S; Otto W; Wieland W; Burger M; Fritsche HM
Eur Urol; 2012 Oct; 62(4):662-70. PubMed ID: 22534059
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.
Buchner A; May M; Burger M; Bolenz C; Herrmann E; Fritsche HM; Ellinger J; Höfner T; Nuhn P; Gratzke C; Brookman-May S; Melchior S; Peter J; Moritz R; Tilki D; Gilfrich C; Roigas J; Zacharias M; Hohenfellner M; Haferkamp A; Trojan L; Wieland WF; Müller SC; Stief CG; Bastian PJ
Eur J Surg Oncol; 2013 Apr; 39(4):372-9. PubMed ID: 23465180
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
11. Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
Nakagawa T; Taguchi S; Uemura Y; Kanatani A; Ikeda M; Matsumoto A; Yoshida K; Kawai T; Nagata M; Yamada D; Komemushi Y; Suzuki M; Enomoto Y; Nishimatsu H; Ishikawa A; Nagase Y; Kondo Y; Tanaka Y; Okaneya T; Hirano Y; Shinohara M; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Urol Oncol; 2017 Jul; 35(7):457.e15-457.e21. PubMed ID: 28110856
[TBL] [Abstract][Full Text] [Related]
12. Impact of body mass index on the oncological outcomes of patients treated with radical cystectomy for muscle-invasive bladder cancer.
Dabi Y; Rouscoff Y; Anract J; Delongchamps NB; Sibony M; Saighi D; Zerbib M; Peyraumore M; Xylinas E
World J Urol; 2017 Feb; 35(2):229-235. PubMed ID: 27272203
[TBL] [Abstract][Full Text] [Related]
13. The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy.
Marks P; Gild P; Soave A; Janisch F; Minner S; Engel O; Vetterlein MW; Shariat SF; Sauter G; Dahlem R; Fisch M; Rink M
Surg Oncol; 2019 Mar; 28():208-213. PubMed ID: 30851902
[TBL] [Abstract][Full Text] [Related]
14. Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder.
Wang LC; Xylinas E; Kent MT; Kluth LA; Rink M; Jamzadeh A; Rieken M; Al Hussein Al Awamlh B; Trinh QD; Sun M; Karakiewicz PI; Novara G; Chrystal J; Zerbib M; Scherr DS; Lotan Y; Vickers A; Shariat SF
Urol Oncol; 2014 May; 32(4):433-40. PubMed ID: 24433754
[TBL] [Abstract][Full Text] [Related]
15. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802
[TBL] [Abstract][Full Text] [Related]
16. Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy.
Gierth M; Mayr R; Aziz A; Krieger S; Wullich B; Pycha A; Lodde M; Salvadori U; Bründl J; Fritsche HM; Hofstädter F; Pawlik MT; Otto W; May M; Burger M; Denzinger S
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1819-26. PubMed ID: 25832016
[TBL] [Abstract][Full Text] [Related]
17. Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
Rink M; Lee DJ; Kent M; Xylinas E; Fritsche HM; Babjuk M; Brisuda A; Hansen J; Green DA; Aziz A; Cha EK; Novara G; Chun FK; Lotan Y; Bastian PJ; Tilki D; Gontero P; Pycha A; Baniel J; Mano R; Ficarra V; Trinh QD; Tagawa ST; Karakiewicz PI; Scherr DS; Sjoberg DD; Shariat SF;
BJU Int; 2013 Mar; 111(3 Pt B):E30-6. PubMed ID: 22938654
[TBL] [Abstract][Full Text] [Related]
18. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-to-lymphocyte ratio as a prognostic factor for patients with urothelial carcinoma of the bladder following radical cystectomy.
Zattoni F; Novara G; Iafrate M; Carletti F; Reitano G; Randazzo G; Ceccato T; Betto G; Dal Moro F
Cent European J Urol; 2023; 76(2):90-103. PubMed ID: 37483852
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
Fritsche HM; May M; Denzinger S; Otto W; Siegert S; Giedl C; Giedl J; Eder F; Agaimy A; Novotny V; Wirth M; Stief C; Brookman-May S; Hofstädter F; Gierth M; Aziz A; Kocot A; Riedmiller H; Bastian PJ; Toma M; Wieland WF; Hartmann A; Burger M
Eur Urol; 2013 Apr; 63(4):739-44. PubMed ID: 23079053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
